Need professional-grade analysis? Visit stockanalysis.com
$244.97B
48.60
N/A
0.17%
PharmaEssentia (6446) trades on TW in TWD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at TWD650.00, down 0.46% from the previous close.
Over the past year, 6446 has traded between a low of TWD434.30 and a high of TWD779.00. The stock has gained 49.7% over this period. It is currently 16.6% below its 52-week high.
PharmaEssentia has a market capitalization of $244.97B, with a price-to-earnings ratio of 48.60 and a dividend yield of 0.17%.
PharmaEssentia Corporation, a biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan. Its products include BESREMi, an interferon therapy indicated for polycythemia vera, essential thrombocythemia, PMF, and adult T-cell leukemias. The company also develops Ropeg + anti PD-1; PEG-IL-2 (P11838); PEG-Cytokines; PD-1-IL-2v; ADC; ADCS; NY-ESO-1 TCR-T; and Novel TCR-T for the treatment of solid tumor and immunology. PharmaEssentia Corporation was founded in 1990 and is headquartered in Taipei, Taiwan.
Side-by-side comparison against top Healthcare peers.